Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01a96e8bbea00eeaa0b50c2a0c000dba |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70514 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7051 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N63-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 |
filingDate |
1995-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a9a36dcf98fde6045a7ed4904d14774 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02105088696041b5654d42830b7d08c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac5d7441ab6fc275cd2ec0fff59c1d3f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20eac19b2f6919bf92376aeb66a4364d |
publicationDate |
1996-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9603883-A1 |
titleOfInvention |
Cells bearing cd4 decoy receptors and related molecules and methods |
abstract |
Disclosed is a method of treating HIV in a mammal involving administering to the mammal an effective amount of therapeutic cells expressing a membrane-bound, proteinaceous chimeric receptor comprising an extracellular portion which includes a fragment of CD4 which is capable of specifically recognizing and binding the HIV-infected cell but which does not mediate HIV infection. Also disclosed are cells which express these CD4 receptors and DNA and vectors encoding the receptors. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107849149-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021061809-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7393942-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021061856-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021061863-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11617766-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4112639-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11202801-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023275402-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11440946-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021061862-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018057562-A1 |
priorityDate |
1994-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |